Patents by Inventor Henry Miller

Henry Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150152108
    Abstract: The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
    Type: Application
    Filed: November 19, 2014
    Publication date: June 4, 2015
    Inventors: Charles A. BLUM, Richard Dana Caldwell, Rebecca Casaubon, Jeremy S. Disch, Ryan Michael Fox, Karsten Koppetsch, William Henry Miller, Pui Yee NG, Christopher Oalmann, Robert B. Perni, Bruce G. Szczepankiewicz, Brian White
  • Publication number: 20150141436
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: January 23, 2015
    Publication date: May 21, 2015
    Inventors: William Henry Miller, Xinrong Tian, Sharad Kumar Verma
  • Publication number: 20150126522
    Abstract: This invention relates to novel substituted benzamides according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 7, 2015
    Applicant: GlaxoSmithKline LLC
    Inventors: Joelle Lorraine Burgess, Celine Duquenne, Steven David Knight, William Henry Miller, Kenneth Allen Newlander, Sharad Kumar Verma
  • Patent number: 9021736
    Abstract: A fishing line float and spool device is provided having a rounded, buoyant structure, and an arraignment that allows a length of fishing line to be independently supported from the water surface. The device comprises a first and second side having a perimeter flange and an inset channel therebetween for supporting the fishing line about the perimeter of the device. A plurality of notches is disposed through the flanges of each of the float sides. The fishing line attaches around the float and is extended therefrom, whereby the notches allow the line to be tied off such that when the line is struck by a fish the float flips over for notification purposes. The center of the float includes an aperture therethrough for assisting the user when tying off the fishing line, while also providing a support for an external hand crank reel or a lighted pole.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: May 5, 2015
    Inventor: Henry Miller
  • Publication number: 20140343056
    Abstract: Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: September 12, 2012
    Publication date: November 20, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Joelle Lorraine Burgess, Neil W. Johnson, Steven David Knight, Louis Vincent LaFrance, III, William Henry Miller, Kenneth Allen Newlander, Stuart Paul Romeril, Meagan B. Rouse, Dominic Suarez, Xinrong Tian, Sharad Kumar Verma
  • Patent number: 8765792
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: July 1, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Steven David Knight, William Henry Miller, Kenneth Allen Newlander, Sharad Kumar Verma
  • Publication number: 20140164903
    Abstract: Computer-implemented methods and systems are provided for creating web-based books simulating the experience of reading a physical book. The web-based books are directly editable by users in real-time.
    Type: Application
    Filed: July 9, 2013
    Publication date: June 12, 2014
    Applicant: Memorial e Libraries, Inc.
    Inventors: Edward F. Paquette, Brandon Roberson, Karl Schwaerzle, Michael Richards, Henry Miller, Kyle Jalbert
  • Publication number: 20130298440
    Abstract: A fishing line float and spool device is provided having a rounded, buoyant structure, and an arraignment that allows a length of fishing line to be independently supported from the water surface. The device comprises a first and second side having a perimeter flange and an inset channel therebetween for supporting the fishing line about the perimeter of the device. A plurality of notches is disposed through the flanges of each of the float sides. The fishing line attaches around the float and is extended therefrom, whereby the notches allow the line to be tied off such that when the line is struck by a fish the float flips over for notification purposes. The center of the float includes an aperture therethrough for assisting the user when tying off the fishing line, while also providing a support for an external hand crank reel or a lighted pole.
    Type: Application
    Filed: April 12, 2013
    Publication date: November 14, 2013
    Inventor: Henry Miller
  • Publication number: 20130245016
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: November 30, 2011
    Publication date: September 19, 2013
    Inventors: Steven David Knight, William Henry Miller, Kenneth Allen Newlander, Sharad Kumar Verma
  • Patent number: 8082909
    Abstract: The present invention is a toy projectile launcher in the form of a role play accessory such as a belt. The belt assembly includes a strap, a launcher housing, and projectiles stored on the belt strap. The belt strap feeds through the launcher housing so that projectiles may be launched from the strap. In one embodiment the launcher is hand-held, and includes a handle which serves both as a means for holding the launcher during operation and as a power switch for the launcher. Projectiles may be discharged singly from the launcher or continuously in a rapid-fire mode.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: December 27, 2011
    Assignee: Mattel, Inc.
    Inventors: Brandon C. Sopinsky, Binh Luong, Steed Sun, Peter Fan, Henry Miller
  • Publication number: 20110041822
    Abstract: The present invention is a toy projectile launcher in the form of a role play accessory such as a belt. The belt assembly includes a strap, a launcher housing, and projectiles stored on the belt strap. The belt strap feeds through the launcher housing so that projectiles may be launched from the strap. In one embodiment the launcher is hand-held, and includes a handle which serves both as a means for holding the launcher during operation and as a power switch for the launcher. Projectiles may be discharged singly from the launcher or continuously in a rapid-fire mode.
    Type: Application
    Filed: November 2, 2010
    Publication date: February 24, 2011
    Applicant: MATTEL, INC.
    Inventors: Brandon C. Sopinsky, Binh Luong, Steed Sun, Peter Fan, Henry Miller
  • Patent number: 7857811
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: December 28, 2010
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Matthias Vaska, John E. Crowe, Gary Henry Miller, Jonathan L. Podmore, Gerard Champsaur, Drew Hoffman, Casey Tansey
  • Patent number: 7841327
    Abstract: The present invention is a toy projectile launcher in the form of a role play accessory such as a belt. The belt assembly includes a strap, a launcher housing, and projectiles stored on the belt strap. The belt strap feeds through the launcher housing so that projectiles may be launched from the strap. In one embodiment the launcher is hand-held, and includes a handle which serves both for holding the launcher during operation and as a power switch for the launcher. Projectiles may be discharged singly from the launcher or continuously in a rapid-fire mode.
    Type: Grant
    Filed: September 15, 2007
    Date of Patent: November 30, 2010
    Assignee: Mattel, Inc.
    Inventors: Brandon C. Sopinsky, Binh Luong, Steed Sun, Peter Fan, Henry Miller
  • Patent number: 7824403
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: November 2, 2010
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Matthias Vaska, John E. Crowe, Gary Henry Miller, Jonathan L. Podmore, Gerard Champsaur, Drew Hoffman, Casey Tansey
  • Patent number: 7824402
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: November 2, 2010
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Matthias Vaska, John E. Crowe, Gary Henry Miller, Jonathan L. Podmore, Gerard Champsaur, Drew Hoffman, Casey Tansey
  • Patent number: 7759340
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: July 20, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Patent number: 7709496
    Abstract: 2H-chromen-2-one derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: May 4, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Alan T. Price
  • Patent number: 7709472
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: May 4, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Patent number: 7691850
    Abstract: Compounds of formula (I) and derivatives thereof: compositions containing them, their preparation and their use as antibacterials.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: April 6, 2010
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Israil Pendrak, Mark Andrew Seefeld
  • Patent number: RE44613
    Abstract: The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: November 26, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Kevin J. Duffy, William Henry Miller, Andrea K. Myers, Antony N. Shaw, Michael N. Zimmerman